Right bundle branch block and risk of cardiovascular mortality: the Ibaraki Prefectural Health Study

Naomi Nakazawa1,2,3, Tomoko Ishizu4,5, Toshimi Sairenchi3,6

  • 1Department of Clinical Laboratory Medicine, University of Tsukuba, Tsukuba, Japan.

Heart and Vessels
|September 25, 2021
PubMed

Insights

Complete right bundle branch block (CRBBB) is not always benign. This study found CRBBB increases cardiovascular mortality risk, especially in younger women and older men, even without symptoms.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Historically, right bundle branch block (RBBB) was considered benign in asymptomatic individuals, based on limited older research.
  • Recent evidence suggests a potential underestimation of RBBB's cardiovascular implications.
  • The association between complete right bundle branch block (CRBBB) and cardiovascular outcomes requires further large-scale investigation.

Purpose of the Study:

  • To investigate the association between CRBBB and subsequent cardiovascular mortality in a large Japanese general population cohort.
  • To identify specific demographic groups at higher risk associated with CRBBB.
  • To inform clinical awareness regarding CRBBB in seemingly healthy individuals.

Main Methods:

  • A large community-based cohort study involving 90,022 individuals in Japan, with data assessed from annual health check-ups.
  • Longitudinal follow-up from 1993 to the end of 2016.
  • Statistical analysis using Cox proportional hazards models and log-rank tests to determine the association between CRBBB and cardiovascular mortality.

Main Results:

  • CRBBB was identified in 1.5% (1,344 participants) of the study cohort.
  • CRBBB was significantly associated with an increased risk of cardiovascular mortality (HR 1.21; 95% CI 1.06-1.38) after adjusting for confounders.
  • The risk was particularly elevated in women under 65 years (HR 2.00) and men 65 years and older (HR 1.28).

Conclusions:

  • CRBBB is associated with an increased risk of cardiovascular mortality, challenging the historical view of it being benign.
  • Specific subgroups, namely pre-menopausal women and elderly men, face a disproportionately higher risk.
  • Clinicians should consider CRBBB a potential risk factor for cardiovascular mortality, even in asymptomatic patients, particularly within these identified demographic groups.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
423
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
765
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
90